Developing treatments for underserved diseases can be surprisingly profitable for biotechs, we asked the experts to tell us more about how best to exploit these areas. We hear a lot about cancer therapies or drugs to target heart disease in ...
The post How to Capitalize on Opportunities in Underserved Disease Areas appeared first on Labiotech.eu.
Original Article: How to Capitalize on Opportunities in Underserved Disease Areas